Optoelectronic Devices for Vision Restoration

Purpose of Review The goal is providing an update to the latest research surrounding optoelectronic devices, highlighting key studies and benefits and limitations of each device. Recent Findings The Argus II demonstrated long-term safety after a 5-year follow-up. Due to lack of tack fixation, subretinal implants appear to displace over time. PRIMA’s completed primate trial showed initial safety and potential for improved vision, resulting in ongoing clinical trials; Bionic Vision Australia developed a new 44-electrode suprachoroidal device currently in a clinical trial. Orion (cortical stimulation) is currently undergoing a clinical trial to demonstrate safety. Summary Devices using external camera for images are unaffected by corneal or lens opacities but disconnect eye movements from image perception, while the opposite is true for implants directly detecting light. Visual acuity provided by devices is more complicated than implant electrode density, and new devices aim to target this with innovative approaches.

[1]  G. Cosnard,et al.  Intraorbital implantation of a stimulating electrode for an optic nerve visual prosthesis. Case report. , 2006, Journal of neurosurgery.

[2]  R Clay Reid,et al.  Demonstration of artificial visual percepts generated through thalamic microstimulation , 2007, Proceedings of the National Academy of Sciences.

[3]  J. Dowling,et al.  Current and future prospects for optoelectronic retinal prostheses , 2009, Eye.

[4]  Sébastien Joucla,et al.  Improved Focalization of Electrical Microstimulation Using Microelectrode Arrays: A Modeling Study , 2009, PloS one.

[5]  Alfred Stett,et al.  Subretinal electronic chips allow blind patients to read letters and combine them to words , 2010, Proceedings of the Royal Society B: Biological Sciences.

[6]  Jessy D. Dorn,et al.  Interim results from the international trial of Second Sight's visual prosthesis. , 2012, Ophthalmology.

[7]  Chris E. Williams,et al.  Visual cortex responses to suprachoroidal electrical stimulation of the retina: effects of electrode return configuration. , 2012, Journal of neural engineering.

[8]  L. Ayton,et al.  Choroidal thickness profiles in retinitis pigmentosa , 2013, Clinical & experimental ophthalmology.

[9]  Chris E. Williams,et al.  Visual prostheses for the blind. , 2013, Trends in biotechnology.

[10]  G. Suaning,et al.  Attaining higher resolution visual prosthetics: a review of the factors and limitations , 2013, Journal of neural engineering.

[11]  Angelika Braun,et al.  Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS , 2013, Proceedings of the Royal Society B: Biological Sciences.

[12]  Florian Waschkowski,et al.  Development of very large electrode arrays for epiretinal stimulation (VLARS) , 2014, BioMedical Engineering OnLine.

[13]  Chris E. Williams,et al.  First-in-Human Trial of a Novel Suprachoroidal Retinal Prosthesis , 2014, PloS one.

[14]  R. Massof,et al.  Psychometric properties of the PLoVR ultra-low vision (ULV) questionnaire , 2014 .

[15]  A. Sher,et al.  Photovoltaic restoration of sight with high visual acuity , 2015, Nature Medicine.

[16]  Ryad Benosman,et al.  Synthetic 3D diamond-based electrodes for flexible retinal neuroprostheses: Model, production and in vivo biocompatibility. , 2015, Biomaterials.

[17]  Gislin Dagnelie,et al.  Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. , 2016, Ophthalmology.

[18]  Ziad M. Hafed,et al.  Oculomotor behavior of blind patients seeing with a subretinal visual implant , 2016, Vision Research.

[19]  Jessy D. Dorn,et al.  Improvements in vision‐related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis , 2016, Clinical & experimental optometry.

[20]  Albrecht Rothermel,et al.  Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations , 2017, Front. Neurosci..

[21]  E. Zrenner,et al.  The Subretinal Implant ALPHA: Implantation and Functional Results , 2017 .

[22]  J. Sommerhalder,et al.  Prospects and Limitations of Spatial Resolution , 2017 .

[23]  Avi Caspi,et al.  Retinotopic to Spatiotopic Mapping in Blind Patients Implanted With the Argus II Retinal Prosthesis. , 2017, Investigative ophthalmology & visual science.

[24]  Udo Greppmaier,et al.  Laboratory and clinical reliability of conformally coated subretinal implants , 2017, Biomedical microdevices.

[25]  Jennifer I. Lim,et al.  ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. , 2018, Retina.

[26]  W. Mokwa,et al.  Biocompatibility of photodiode structures used for epiretinal prosthesis extended by an integrated epiretinal recording (OPTO-EPIRET) , 2018 .

[27]  M. Nami,et al.  The Argus-II Retinal Prosthesis Implantation; From the Global to Local Successful Experience , 2018, Front. Neurosci..

[28]  Nader Pouratian,et al.  Brain Machine Interfaces for Vision Restoration: The Current State of Cortical Visual Prosthetics , 2018, Neurotherapeutics.

[29]  Joel Villalobos,et al.  Safety Studies for a 44-Channel Suprachoroidal Retinal Prosthesis: A Chronic Passive Study. , 2018, Investigative ophthalmology & visual science.

[30]  R. Devenyi,et al.  Rehabilitation of lost functional vision with the Argus II retinal prosthesis. , 2018, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[31]  Robert E. MacLaren,et al.  Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa , 2017, Ophthalmology.

[32]  W. Mokwa,et al.  Surgical feasibility and biocompatibility of the OptoEpiret retinal stimulator , 2019 .

[33]  Ryad Benosman,et al.  Behavioural responses to a photovoltaic subretinal prosthesis implanted in non-human primates , 2019, Nature Biomedical Engineering.

[34]  P. Szurman,et al.  First Simultaneous Explantation and Re-Implantation of an Argus II Retinal Prosthesis System. , 2019, Ophthalmic surgery, lasers & imaging retina.

[35]  B. Wilhelm,et al.  Changes in microchip position after implantation of a subretinal vision prosthesis in humans , 2018, Acta ophthalmologica.

[36]  J. Sahel,et al.  Six-Month Safety and Efficacy of the Intelligent Retinal Implant System II Device in Retinitis Pigmentosa. , 2019, Ophthalmology.

[37]  Avi Caspi,et al.  Trade-Off Between Field-of-View and Resolution in the Thermal-Integrated Argus II System , 2018, Translational vision science & technology.

[38]  Yi Zhang,et al.  Histopathologic Assessment of Optic Nerves and Retina From a Patient With Chronically Implanted Argus II Retinal Prosthesis System , 2019, Translational vision science & technology.

[39]  Samuel A. Titchener,et al.  A 44 channel suprachoroidal retinal prosthesis: initial psychophysical results , 2019 .

[40]  M. Mehta,et al.  Retinitis Pigmentosa: Review of Current Treatment. , 2019, International ophthalmology clinics.

[41]  Jessy D. Dorn,et al.  One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study. , 2019, JAMA ophthalmology.

[42]  Jennifer I. Lim,et al.  ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. , 2020 .

[43]  Chiara Bartolozzi,et al.  Event-Based Vision: A Survey , 2020, IEEE Transactions on Pattern Analysis and Machine Intelligence.